vTv Therapeutics (VTVT) Misses Q1 EPS by 117c

vTv Therapeutics (NASDAQ: VTVT) reported Q1 EPS of ($1.17). Revenue for the quarter came in at $1 million.

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
• Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight